ReviewDeutsches Arzteblatt international2010
The origins of colorectal carcinoma: specific nomenclature for different pathways and precursor lesions.
Review in Deutsches Arzteblatt international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 35 citations in OpenAlex.
- [BRAF-V600E testing in metastatic colorectal cancer and new, chemotherapy-free therapy options. German version].Der Pathologe · 2021Review
- BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options.Der Pathologe · 2021Review
- [Histomorphological and molecular-pathological prognostic factors in colorectal cancer].Der Pathologe · 2020Review
- Association of lncRNA-p53 regulatory network (lincRNA-p21, lincRNA-ROR and MALAT1) and p53 with the clinicopathological features of colorectal primary lesions and tumors.Oncology letters · 2020Article
- Long Non-Coding RNA LINC00239 Functions as a Competitive Endogenous RNA by Sponging microRNA-484 and Enhancing KLF12 Expression to Promote the Oncogenicity of Colorectal Cancer.OncoTargets and therapy · 2020Article
- FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway.American journal of translational research · 2018Article
- Factors associated with reclassification of hyperplastic polyps after pathological reassessment from screening and surveillance colonoscopies.International journal of colorectal disease · 2016Article
- Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer.PloS one · 2016Article
- Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.International journal of clinical and experimental pathology · 2015Article
- A functional variant at miR-520a binding site in PIK3CA alters susceptibility to colorectal cancer in a Chinese Han population.BioMed research international · 2015Article
- Association between EZH2 polymorphisms and colorectal cancer risk in Han Chinese population.Medical oncology (Northwood, London, England) · 2014Article
- [Precancerous colorectal tumors].Der Internist · 2013Article
- Serrated pathway: alternative route to colorectal cancer.World journal of gastroenterology · 2013Review
- Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas.PloS one · 2012Article
- [Serrated precursor lesions].Der Pathologe · 2011Review
- [Standardized and structured histopathological evaluation of colorectal polyps: a practical checklist against the background of the new WHO classification].Der Pathologe · 2011Review
- Terminology is unclear.Deutsches Arzteblatt international · 2011Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe widespread application of molecular methods in pathology has yielded steady advances in our understanding of the origins of colorectal carcinoma. Multiple pathways of carcinogenesis have been demonstrated on the molecular level and visualized on the histopathological level. The WHO has accordingly proposed a number of new designations and terms, particularly for precursor lesions, in order to establish a uniform standard for clinical diagnosis. These should be put into practice at once.
methodsIn this article, we explain the concept of intraepithelial neoplasia, which replaces the older concept of dysplasia. Moreover, we use this concept in describing a new mechanism of carcinogenesis for colorectal carcinoma, on the basis of a selective review of the literature. We estimate the frequency of precursor lesions according to the new concept using data from our own patient collective. Finally, we discuss the clinical consequences, which have been addressed in the German S3 guideline for colorectal carcinoma.
resultsThe new type of precursor lesion, called "sessile serrated adenoma" (SSA), accounts for some 7% of all adenomas in our patient collective and is usually found in the right hemicolon. Traditional serrated adenomas (TSA) made up 1% to 3% of our cases and were found mainly in the left hemicolon and rectum.
conclusionOur observations on the frequency and location of serrated adenomas accord with the initial findings published in the international literature. In view of the risk that serrated lesions will progress more rapidly, it is recommended that they should be completely removed, with follow-up at a short interval thereafter (three years according to the German S3 guidelines).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.